Mainz Biomed Works To Ensure Early Cancer Detection W\90% 5 Year Survival By Improving Test Access from eset endpoint advanced Watch Video
Preview(s): Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Your browser does not support playing the video.Please download the video!
⏲ Duration: 1:55 👁 View: 285K times ✓ Published: 19-Jun-2024
Description: Advanced Screening Equals Early Detection: Cancer screening has to be simple, readily available, and affordable to be effective, which is where Mainz Biomed comes in. The molecular genetics diagnostic company specializing in the early detection of cancer is revolutionizing the colorectal cancer testing industry with ColoAlert, its flagship product.